GleanMark

OPTISPAN Trademark

OPTISPAN is a USPTO trademark filed by Optispan, Inc.. Status: Pending.

Trademark Facts

MarkOPTISPAN
Serial Number98350452
StatusPending
Filing Date2024-01-10
Mark TypeWord
Nice Classes009 (Electronics & Software), 035 (Advertising & Business), 041 (Education & Entertainment), 042 (Software & IT)
OwnerOptispan, Inc.
Attorney of RecordKevin S. Costanza
Prosecution Events25
Latest EventEXRA on 2025-12-23

Goods & Services

Coaching services in the fields of medicine, preventative healthcare, and wellness; Recorded computer software for use in data management, data analysis, data integration, and data reporting, excluding software for use in the field of financial services; downloadable computer software for use in data management, data analysis, data integration, and data reporting, excluding software for use in the field of financial services; downloadable and recorded software applications for use in data management, data analysis, data integration, and data reporting, excluding applications for use in the field of financial services; downloadable and recorded software for use in data management, data analysis, data integration, and data reporting in the fields of medicine, preventative healthcare, and wellness; downloadable and recorded software applications for use in the development and testing of new pharmaceuticals; Business development services; business development consulting services in the fields of medicine, preventative healthcare, and wellness; business development services, namely, developing and managing scientific medical wellness programs; employment staffing services, namely, employment staffing of coaches; Technical research and development in the field of technology products, diagnostic biomarkers, software, and protocols for use in providing proactive, preventative healthcare services; software as a service (SaaS) services featuring software for use in data analysis, data integration, and data reporting in the fields of medicine, preventative healthcare, and wellness; software as a service (SaaS) services featuring software for use in the development and testing of new pharmaceuticals

Related